Abnormal HMGB1 expression is also closely related to anxiety and depression (Lu et al. 2024; Xu et al. 2020), suggesting that HMGB1-induced microglial activation may be a significant factor in the development of anxiety and depression in CRS patients. Here, HMGB1 is linked to depressive symptom measurement.